Fintel reports that on April 21, 2026, Rothschild & Co upgraded their outlook for Colgate-Palmolive (NYSE:CL) from Neutral to Buy. Analyst Price Forecast Suggests 18.60% Upside As of April 14, 2026, ...

Credit: Colgate Whether we like it or not, AI is infiltrating almost every aspect of our lives, including advertising. The ...

Colgate-Palmolive has been upgraded to a “Buy” rating by analysts at Rothschild & Co Redburn, who cite the company’s ...

Colgate-Palmolive recently disclosed that long-time Chief Legal Officer Jennifer M. Daniels plans to retire in 2026, with ...

Colgate-Palmolive (CL) has drawn fresh attention after recent price moves, with the stock showing a 7.5% decline over the ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the circulation of counterfeit Colgate toothpaste. In a statement on Sunday, the agency said it ...

Jefferies analyst Kaumil Gajrawala maintained a Hold rating on Colgate-Palmolive today and set a price target of $88.00. Gajrawala covers the Consumer Defensive sector, focusing on stocks such as Coca ...

Ltd is quoting at Rs 2090, up 5.69% on the day as on 12:49 IST on the NSE. The stock is down 17.85% in last one year as compared to a 0.61% gain in NIFTY and a 11.6% gain in the Nifty FMCG index.

NAFDAC issues a public alert about counterfeit and unregistered fake Colgate toothpaste circulating in Nigeria, posing a risk ...

As America celebrates 250 years, Colgate-Palmolive CEO Noel Wallace reflects on how the company evolved from a small soap business into a global leader in oral care — driven by innovation, purpose, ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has cautioned citizens about the spread of unapproved and potentially fake toothpaste products falsely linked to Colgate.

Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.